Figure 1. Non-relapse mortality and relapse incidence in patients receiving a myeloablative regimen.
The cumulative incidence of non-relapse mortality and relapse by conditioning regimen (TBF-MAC vs BF-MAC).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.